Natalie Wright, MD
Dermatology · Plano, TXNPI 1699092866
Payments from drug & device makers
Across 929 payments — averaging $380.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$320K
- Novartis$11K
- E.r. Squibb & Sons, L.L.C.$6K
- UCB, Inc.$3K
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$2K
- Sanofi$2K
- plus $10K from 30 others
Across 1 payment — averaging $1650.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$2K
What the payments were for
- Consulting fees$60,04617%
- Speaking & faculty fees$247,49870%
- Travel & lodging$24,7477%
- Food & beverage$20,8786%
- Education$2670%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 405 | $319,703 |
| Novartis | 76 | $10,604 |
| E.r. Squibb & Sons, L.L.C. | 18 | $5,800 |
| UCB, Inc. | 22 | $3,153 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 20 | $2,294 |
| Sanofi | 35 | $1,958 |
| Arcutis Biotherapeutics, Inc. | 9 | $1,717 |
| Lilly USA, LLC | 47 | $985 |
| Sun Pharmaceutical Industries Inc. | 47 | $962 |
| Regeneron Healthcare Solutions, Inc. | 37 | $935 |
| Johnson & Johnson | 31 | $727 |
| Pfizer | 38 | $694 |
| VYNE Pharmaceuticals Inc. | 14 | $630 |
| Biofrontera Inc. | 13 | $587 |
| Incyte Corporation | 20 | $486 |
| Almirall LLC | 10 | $340 |
| Amgen | 14 | $327 |
| Dermavant Sciences, Inc. | 20 | $280 |
| Galderma Laboratories, L.p. | 14 | $235 |
| Kerecis Limited | 1 | $147 |
| LEO Pharma Inc. | 5 | $119 |
| Boehringer Ingelheim | 5 | $117 |
| Botanix SB Inc | 6 | $109 |
| Comsort, Inc | 1 | $100 |
| Sanofi-aventis U.S. LLC | 2 | $98 |
| EPI Health, LLC | 4 | $75 |
| Octapharma USA, Inc. | 2 | $44 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $40 |
| Mayne Pharma Commercial LLC | 3 | $32 |
| Paratek Pharmaceuticals, Inc. | 2 | $31 |
| Dermira, Inc. | 1 | $22 |
| Nabriva Therapeutics, PLC | 1 | $22 |
| Aclaris Therapeutics, Inc. | 1 | $21 |
| Taro Pharmaceuticals USA, Inc. | 1 | $19 |
| Icad, Inc | 1 | $13 |
| Bristol Myers Squibb | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$353,437 in reported general payments places this provider in the 95th percentile of 1,098 dermatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 24 | $245,733 |
| Dupixent SyringeDupilumab | 13 | $48,647 |
| Mycophenolate Mofetil | 51 | $3,250 |
| Clobetasol Propionate | 93 | $2,846 |
| Metronidazole | 48 | $2,061 |
| Ketoconazole | 151 | $1,723 |
| Dutasteride | 57 | $1,670 |
| Pimecrolimus | 11 | $1,580 |
| Tacrolimus | 13 | $1,275 |
| Fluocinonide | 36 | $1,233 |
| Doxycycline Hyclate | 56 | $1,109 |
| Triamcinolone Acetonide | 161 | $1,048 |
| Clindamycin Phosphate | 31 | $982 |
| Minoxidil | 139 | $861 |
| Betamethasone Dipropionate | 11 | $739 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Plano
- Seemal DesaiPlano$1.1M
- Sam AwanPlano$586K
- Stephen TyringWebster$14.1M
- Edward LainAustin$12M
- Mark LeeSan Antonio$10.9M
- John BrowningSan Antonio$10.7M
- Craig TellerBellaire$7.7M
- Patricia LeeWebster$7.2M
- Jennifer CatherDallas$4.9M
- Michael MigdenHouston$3.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.